Viewing StudyNCT00084578



Ignite Creation Date: 2024-05-05 @ 11:35 AM
Last Modification Date: 2024-10-26 @ 9:10 AM
Study NCT ID: NCT00084578
Status: WITHDRAWN
Last Update Posted: 2013-07-15
First Post: 2004-06-10

Brief Title: Celecoxib and Rosiglitazone in Treating Patients Who Are Undergoing Cystoscopic Surveillance for Early-Stage Noninvasive Carcinoma of the Bladder or Radical Cystectomy for Muscle-Invasive Carcinoma of the Bladder
Sponsor: Fox Chase Cancer Center
Organization: Fox Chase Cancer Center

Conditions & Keywords Data

Conditions:
Name
Bladder Cancer
Keywords:
Name View
transitional cell carcinoma of the bladder View
stage 0 bladder cancer View
stage I bladder cancer View
stage II bladder cancer View
stage III bladder cancer View
stage IV bladder cancer View